A left atrial appendage closure is a procedure your doctor may recommend if: you have atrial fibrillation (also known as AF or AFib) or you are not a good candidate for taking blood thinner medication ...

Cleveland-based University Hospitals Harrington Heart & Vascular Institute became the first in the world to implant Medtronic’s Penditure left atrial appendage exclusion system through a minimally ...

Atrial fibrillation is a common heart condition characterized by a rapid, irregular heartbeat stemming from the heart's upper chamber. It is a leading cause of stroke from clots that form in a small ...

MASON, Ohio., AtriCure, Inc., a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage management (LAAM), today announced that it has launched the AtriClip FLEX•V™ ...

Medtronic said Monday it is launching a device in the U.S. designed to close the left atrial appendage (LAA) of the heart in patients undergoing cardiac surgery. The treatment is intended for patients ...

MASON, Ohio--(BUSINESS WIRE)--AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage management, today announced that it has launched ...

Please provide your email address to receive an email when new articles are posted on . Medtronic announced the launch of its LAA exclusion system in the U.S. after its August 2023 FDA clearance. The ...

Cleveland, OH - The AtriClip Gillinov-Cosgrove Left Atrial Appendage (LAA) Exclusion system (AtriCure, West Chester, OH) has been approved by the US FDA for occlusion of the LAA, under direct ...

Stroke prevention is among the major goals in managing nonvalvular atrial fibrillation. Anticoagulant therapy is highly effective at reducing stroke risk, but more than half of patients with atrial ...

For patients with atrial fibrillation (AFib), a common heart rhythm disorder, closing the area of the heart known as the left atrial appendage as an add-on procedure during cardiac surgery was ...

Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...

MASON, Ohio--(BUSINESS WIRE)--AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage management (LAAM), today announced that it has ...